4 December 2015 - Sun Pharmaceutical Industries Ltd., said it has received approval from the U.S. FDA to make a generic version of Novartis AG’s cancer drug Gleevec.

For more details, go to: http://www.bloomberg.com/news/articles/2015-12-04/sun-pharma-gets-fda-approval-for-generic-of-novartis-gleevec